Cogent Biosciences
COGT
COGT
148 hedge funds and large institutions have $1.02B invested in Cogent Biosciences in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
15% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 47
1% more funds holding
Funds holding: 146 → 148 (+2)
12% less call options, than puts
Call options by funds: $1.68M | Put options by funds: $1.91M
Holders
148
Holding in Top 10
6
Calls
$1.68M
Puts
$1.91M
Top Buyers
| 1 | +$32M | |
| 2 | +$30.6M | |
| 3 | +$27.9M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$24.6M |
| 5 |
DM
Deerfield Management
New York
|
+$18.6M |
Top Sellers
| 1 | -$31.9M | |
| 2 | -$17.5M | |
| 3 | -$9.48M | |
| 4 |
Morgan Stanley
New York
|
-$7.33M |
| 5 |
PA
Perceptive Advisors
New York
|
-$5.94M |